Product Information
FT NASAL DECONGEST 30 MG TAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0776 per EA under NDC 70677101701. Its NADAC has been published 161 times since Sep 6, 2023.
Strength
30 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677101701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/6/2023
Pharmacological Classes
Price Statistics
The NADAC for FT NASAL DECONGEST 30 MG TAB has been published 161 times since Sep 6, 2023, and over the history we have for it it has risen 64.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0776 per EA |
|---|---|
| All-time high | $0.0780 (Sep 16, 2026) |
| All-time low | $0.0458 (Jul 17, 2024) |
| 52-week high | $0.0780 |
| 52-week low | $0.0598 |
| Median price | $0.0598 |
| Average price | $0.0595 |
| Largest weekly change | +33.4% (Nov 22, 2023) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT NASAL DECONGEST 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FT NASAL DECONGEST 30 MG TAB, manufactured by Strategic Sourcing Services LLC, is $0.0776 per EA (NDC 70677101701), effective Sep 30, 2026.
How has the price of FT NASAL DECONGEST 30 MG TAB changed over time?
Over the history we have for it, the NADAC for FT NASAL DECONGEST 30 MG TAB has risen 64.1%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FT NASAL DECONGEST 30 MG TAB?
Since Sep 6, 2023, the NADAC for FT NASAL DECONGEST 30 MG TAB has ranged from a low of $0.0458 (Jul 17, 2024) to a high of $0.0780 (Sep 16, 2026), with a median of $0.0598 per EA.
Are there cheaper alternatives to FT NASAL DECONGEST 30 MG TAB?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL DECONGESTANT 30 MG TAB, is $0.0539 per EA — about 30% below FT NASAL DECONGEST 30 MG TAB.
Who manufactures FT NASAL DECONGEST 30 MG TAB?
FT NASAL DECONGEST 30 MG TAB (NDC 70677101701) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.